Cleva Card Report Highlights Client Funds Issue
UK | Care England has partnered with Cleva Card to highlight the issue of adult social care management of client funds. A new report…
AGED CARE
Pilot Projects Begin in Regional NSW
AUSTRALIA | Six rural gap-bridging pilots in regional New South Wales have gotten underway, backed by more than 20 partners. In New South Wales,…
New Care Minutes Performance Statement Requirement
AUSTRALIA | The Australian Government has updated and added new requirements to audit Care Minutes Performance Statements. All residential aged care providers will be…
Tell TiNA Launched by Dementia Australia
AUSTRALIA | Dementia Australia has introduced Tell TiNA, a new app-based tool to support health workers in aged care and disability roles. Tell TiNA,…
P2P Group Partner With NZ Provider
P2P Group Ltd. said it was pleased to announce that a major New Zealand-based disability care provider is commencing an on-premise trial of the…
Summerset Report Q225 Update
Summerset Group reported 402 sales for the quarter ending 30 June 2025, comprising 222 new sales and 180 resales. Summerset CEO Scott Scoullar said…
Ronan McNeill and his Passion for Dementia
University of Otago student Ronan McNeill has a passion for dementia research stemming from the mental decline of his family members. Despite preparing to…
Operators Face Long Road to Profitability
A profitability report has provided operators with a fair assessment of the current industry landscape in New Zealand. A Grant Thornton report on retirement…
Liquidity Standards Win
Ageing Australia said it was pleased that its advocacy has led to the lowering of proposed Liquidity Standards, which would have threatened to strangle…
Care England Welcomes NHS Plan
UK | Care England has welcomed the 10-year plan proposed by the NHS, but said its success hinges on social care leadership and integration….
Cardiovascular and Diabetes Focus
AUSTRALIA | Diabetes and cardiovascular disease are the prime focus for the Australian Government following new investments in health. The Australian Government is investing…
NHS Rejects Proposed Alzheimer’s Drugs
UK | Donanemab and lecanemab have been advised to not be provided on the NHS by the National Institute for Health and Care Excellence….